Bringing structural heart patients better clinical outcomes
Clinical evidence demonstrates the benefits of minimally invasive interventions for patients with structural heart diseases. Detailed information and accurate imaging are crucial to support successful structural heart procedures and better outcomes for TAVI, LAAo and emerging TMVR interventions.
Using routine preoperative CT data, FEops HEARTguide™ simulation-based technology takes preoperative planning to the next level by:
- going beyond simple anatomical measurement, surpassing the ‘overlay technique’ currently used to gauge the size and position of the undeformed device;
- accurately predicting how the device will interact with each unique patient, including the effects of positioning;
- providing physicians with detailed insights that assist in the selection of device size and position.
FEops HEARTguide™ helps clinicians to evaluate device size and position to avoid aortic regurgitation (PVL) and conduction abnormalities. CE mark for FEops HEARTguide™ with indication in TAVI and LAAo was obtained in March 2019. FEops HEARTguide™ is not available for clinical use in the USA.